Cornelia Kamp, M.B.A.

Cornelia Kamp, M.B.A.

Contact Information

University of Rochester Medical Center
School of Medicine and Dentistry
601 Elmwood Ave, Box CU 420694
Rochester, NY 14642

Journal Articles

Showing all 23 journal articles available.

Dworkin, RH, Turk, TC, Katz, NP, Rowbotham MP, Peirce-Sandner S, Cerny I, Clingman CS, Farrar JT, Kamp C, McDermott MP, Rappaport BA, Sandia WS. "Evidence-based clinical trial design for chronic pain pharmacotherapy: A blueprint for ACTION". Pain. 2011; .
Dworkin, R.; Barbano, R.; Tyring, S.; Betts, R.; McDermott, M.; Pennella-Vaughan, J.; Bennett, G.; Berber, E.; Gnann, J.; Irvine, C.; Kamp, C.; Kieburtz, K.; Max, M.; Schmader, K. "A Randomized, Placebo-Controlled Trial of Oxycodone and of Gabapentin for Acute Pain in Herpes Zoster." Pain. 2009; 142: 209-217.
The NINDS NET-PD Investigators (Galpern, W.; MD, primary author). "A Pilot Clinical Trial of Creatine and Minocycline in Early Parkinson Disease: 18-Month Results." Clinical Neuropharmacology. 2008; 31: 141-150.
Parkinson Study Group (Tanner, CM.; primary author). "Pramipexole in Levodopa Treated Parkinson's Disease Patients of African, Asian and Hispanic heritage." Clinical Neuropharmacology. 2007; 30 (2): 72-85.
The NINDS NET-PD Investigators (Kieburtz, K.; Primary author). "A Randomized Clinical Trial of Coenzyme Q10 and GPI-1485 in Early Parkinson's Disease." Neurology. 2007; 68: 20-28.
The NINDS NET-PD Investigators, NET-PD Steering Committee. "A randomized, double-blind, futility clinical trial of creatine and minocycline in early Parkinson's disease." Neurology. 2006; 66: 664-671.
Parkinson Study Group (Karen Blindauer, primary author). "Randomized placebo-controlled study of the nicotinic agonist, 51B-15084 in Parkinson's disease." Neurology. 2006; 66: 408-410.
Parkinson Study Group (Steven Schwid, primary author). "A Randomized Placebo-Controlled Trial of Rasagiline in Levodopa-Treated Patients with Parkinson Disease and Motor Fluctuations." Arch Neurol. 2005; 62: 241-248.
Elm J, Goetz C, Ravina B, Shannon K, Wooten F, Tanner C, Palesch Y, Huang P, Guimaraes P, Kamp C, Tilley B, Kieburtz K, for the NET-PD Investigators. "A Responsive Outcome for Parkinson's Disease Neuroprotection Futility Studies." Annals of Neurology. 2005; 57(2): 197-203.
Comella CL, Jankovic J, Shannon KM, et al. "A Comparison of botulinum toxin serotypes A and B for the treatment of Cervical Dystonia." Neurology. 2005; 65: 1423-1429.
Parkinson Study Group (Steven Schwid, primary author). "The safety and tolerability of a mixed lineage kinase inhibitor (CEP-1347) in PD." Neurology. 2004; 62: 330-332.
Parkinson Study Group (Robert Holloway, primary author). "Pramipexole vs levodopa as initial treatment for Parkinson disease: A 4-year Randomized Controlled Trial." Arch Neurol. 2004; 61(7): 1044-1053.
Noyes K, Dick A, Holloway RG, and the Parkinson Study Group. "Pramipexole vs Levodopa as Initial Treatment for Parkinson's Disease. A Randomized Clinical-economic Trial." Med Decis Making. 2004; 2004: 472-485.
Holloway, RG.; Shouldson, I.; Fahn, S.; Kieburtz, K.; Lang, A.; Marek, K.; McDermott, M.; Seibyl, J.; Weiner, W.; Musch, B.; Kamp, C.; et. al..; Parkinson Study Group. "Pramipexole vs levodopa as initial treatment for Parkinson disease: a 4-year randomized controlled trial." Arch Neurol. 2004; 61(7): 1044-53.
Parkinson Study Group (Karen Blindauer, primary author). "A Controlled Trial of rotigotine Monotherapy in Early Parkinson's Disease." Arch Neurol. 2003; 60: 1721:1728.
Parkinson Study Group (Kenneth Marek, primary author). "Dopamine Transporter Brain Imaging to Assess the Effects of Pramipexole vs Levodopa on Parkinson Disease Progression." JAMA. 2002; 287 (13): 1653-1661.
Sacktor, N.; Schifitto, G.; McDermott, MP.; Marder, K.; McArthur, JC.; Kieburtz, K. "Transdermal selegiline in HIV-associated cognitive impairment: Pilot, placebo-controlled study." Neurology. 2000; 54: 233-235.
Parkinson Study Group (Holloway R, primary author). "Pramipexole vs levodopa as initial treatment for Parkinson disease. A randomized controlled trial." JAMA. 2000; 284: 1931-1938.
Parkinson Study Group. "A randomized controlled trial comparing pramipexole with levodopa in early Parkinson's disease: Design and methods of the CALM-PD study." Clinical Neuropharmacology. 2000; 23: 34-44.
Schifitto, G.; Sacktor, N.; Marder, K.; McDermott, M.; McArthur, JC.; Kieburtz , K.; et al. "Randomized trial of the PAF antagonist lexipafant in HIV-associated cognitive impairment." Neurology. 1999; 53: 391-396.
The Dana Consortium on the Therapy of HIV Dementia and Related Cognitive Disorders (N Sacktor, primary author). "A randomized, double-blind, placebo-controlled trial of deprenyl and thioctic acid in human immunodeficiency virus-associated cognitive impairment." Neurology. 1998; 50: 645-651.
Rifai, Z.; Kazee, AM.; Kamp, C.;, Griggs, RC. "Intranuclear rods in severe congenital nemaline myopathy." Neurology. 1993; 43: 2372-2377.
Schwid SR, Bausch J, Oakes D, Schuchter L, Tanner C, Forrest M, Lang AE, Shoulson I and the PSG PRECEPT Investigators. "Cancer incidence in a trial of an anti-apoptotic agent for Parkinson's Disease." Mov Dis. .


Ravina B, Cummings J, McDermott M, Poole M, Kamp C, Germain JM. "Study Conduct: Academic and Industry Perspectives". Clinical Trials in Neurology: From Idea to Implementation. : Cambridge University Press, 2010.
Dunn C, Chadwick G, Kamp C, Shinaman A. "Participant Recruitment and Retention in Clinical Trials". Protecting Study Volunteers in Research: A Manual for Investigative Sites. Sara Gambrill. Boston: Ken Getz, 2002. 141-149